Ascend Imaging agreement expansion | 06-Oct-2025 | 07:00 | RNS |
University of Virginia Health Hospital agreement | 29-Sep-2025 | 07:00 | RNS |
National Institutes of Health system order | 25-Sep-2025 | 12:14 | RNS |
Half-year Report | 25-Sep-2025 | 07:00 | RNS |
Notice of Results | 16-Sep-2025 | 07:00 | RNS |
Holding(s) in Company | 11-Sep-2025 | 16:36 | RNS |
Submission of new Phase III study protocol to FDA | 12-Aug-2025 | 07:00 | RNS |
Block Listing Six Monthly Return | 24-Jul-2025 | 07:00 | RNS |
Promotion & sales representative agreement | 24-Jun-2025 | 07:00 | RNS |
Result of AGM | 09-Jun-2025 | 16:16 | RNS |
FDA expands XENOVIEW indication | 02-Jun-2025 | 07:00 | RNS |
Dr. Bastiaan Driehuys awarded by ATS | 21-May-2025 | 07:00 | RNS |
Xenon MRI featured prominently at ATS 2025 | 15-May-2025 | 12:48 | RNS |
Ongoing collaboration with Philips | 14-May-2025 | 14:25 | RNS |
Final Results | 08-May-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.000p |
Closing Price Change | 0.000p |
% Change | 0.00 % |
52 Week High | 0.000p |
52 Week Low | 0.000p |
Volume | 0 |
Shares Issued | 1,207.03m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
CFO | Charles Osborne |
CEO | Christopher von Jako |
You are here: research